Transaction in Own Shares

Summary by AI ^BETAClose X

CT Healthcare Trust PLC announced the purchase of 16,875 ordinary shares on the London Stock Exchange on March 26, 2026, at an average price of 126.40 pence per share. These shares will be held in treasury, bringing the total number of shares held in treasury to 258,832,997, with 56,319,312 ordinary shares remaining in issue.

Disclaimer*

CT Healthcare Trust PLC

27 March 2026

CT Healthcare Trust plc
Transaction in own shares


CT Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc.

Date of purchase:	26 March 2026
Number of ordinary shares purchased:	16,875
Trading venue	LSE
Average price paid per share:	126.40p

The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company holds 258,832,997 of its ordinary shares in treasury and has 56,319,312 ordinary shares in issue (excluding treasury shares).

The Company's LEI is: 213800HQ3J3H9YF2UI82

Enquiries:
Columbia Threadneedle Investments
Telephone: +44 (0) 207 464 5000

J.P. Morgan Cazenove
James Bouverat (Sales)
Telephone: +44 (0) 207 134 2224

NSM Funds (UK) Limited
Brian Smith, Ciara McKillop
Contact: bellevue@nsm.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END